{"id":6619,"date":"2014-10-09T11:21:24","date_gmt":"2014-10-09T15:21:24","guid":{"rendered":"http:\/\/www.rxedo.com\/?page_id=6619"},"modified":"2015-01-26T15:55:39","modified_gmt":"2015-01-26T20:55:39","slug":"case-studies","status":"publish","type":"page","link":"https:\/\/www.rxedo.com\/?page_id=6619","title":{"rendered":"Case Studies"},"content":{"rendered":"[vc_row padding_top=”0px” padding_bottom=”0px” border=”none”][vc_column width=”1\/2″]

Actual Results #1<\/span><\/h1>

The following\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u00a0client transitioned from a well known PBM with a traditional service model. The most intriguing aspect of these results is that our client realized these savings without making any changes to its previous benefit design or co-pay structure. Thus, there was no cost shift to the plan members. Additionally, although the client made no adjustments to the plan\u2019s co-pays, the overall cost share for the plan improved by 2%; this was directly related to the fact that\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u2019s billed cost for the drugs was considerably less than the previous PBM.<\/p>\n

The following denotes key statistics based on actual claims experience:<\/p>\n[\/vc_column][vc_column width=”1\/2″ fade=”true” fade_animation=”in” fade_animation_offset=”45px”]

[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″]
[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/2″]

Actual Results\u00a0#2<\/span><\/h1>

The following\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u00a0client transitioned from a well known PBM with a traditional service model. Like the previous case study, this client realized these savings without making any changes to its previous benefit design or co-pay structure. It is interesting to note that although generic utilization actually decreased after the transition, the total cost per claim improved by $8.27 per claim for the plan.<\/p>\n

The following denotes key statistics based on actual claims experience:<\/p>\n[\/vc_column][vc_column width=”1\/2″]

[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″]
[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/2″]

Actual Results\u00a0#3<\/span><\/h1>

The following\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u00a0client transitioned from a well known PBM with a traditional service model. Prior to their transition this particular client looked to\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u00a0for additional cost management strategies. The client acted on\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u2019s recommendation to introduce a co-insurance copay for preferred\/non-preferred (30%\/50%) brand drugs thereby providing a consistent cost share for the plan and its members. Plan members paid the greater of $30\/30% for preferred brand and $50\/50% for non-preferred. Consequently, the co-pay change coupled with\u00a0R<\/span>x<\/sub><\/span>EDO<\/span>\u2019s PBP service model provided the following results:<\/p>\n[\/vc_column][vc_column width=”1\/2″]

[\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″]

Plan implemented a greater of co-insurance copay (30% -50%) to existing flat copay for preferred and non-preferred brand drugs.<\/p>\n[\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row padding_top=”0px” padding_bottom=”0px” border=”none”][vc_column width=”1\/2″][\/vc_column][vc_column width=”1\/2″ fade=”true” fade_animation=”in” fade_animation_offset=”45px”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/2″][\/vc_column][vc_column width=”1\/2″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/2″][\/vc_column][vc_column width=”1\/2″][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-blank-1.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.rxedo.com\/index.php?rest_route=\/wp\/v2\/pages\/6619"}],"collection":[{"href":"https:\/\/www.rxedo.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.rxedo.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.rxedo.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rxedo.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6619"}],"version-history":[{"count":34,"href":"https:\/\/www.rxedo.com\/index.php?rest_route=\/wp\/v2\/pages\/6619\/revisions"}],"predecessor-version":[{"id":7253,"href":"https:\/\/www.rxedo.com\/index.php?rest_route=\/wp\/v2\/pages\/6619\/revisions\/7253"}],"wp:attachment":[{"href":"https:\/\/www.rxedo.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}